tiprankstipranks
HUTCHMED Announces Share Capital Details and Focus
Company Announcements

HUTCHMED Announces Share Capital Details and Focus

HUTCHMED (China) Limited (HK:0013) has released an update.

Don't Miss our Black Friday Offers:

HUTCHMED (China) Limited has announced that its issued share capital consists of 871,561,945 ordinary shares as of October 31, 2024. Each share carries one voting right, and this figure is crucial for shareholders calculating their interest under financial regulations. HUTCHMED is a biopharmaceutical company focused on developing targeted cancer therapies, with a strong presence in oncology and immunology.

For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyHutchmed to receive milestone payment following Takeda launch of Fruzaqla
TipRanks HongKong Auto-Generated NewsdeskHUTCHMED Expands Cancer Treatment Market with Japan Launch
TipRanks HongKong Auto-Generated NewsdeskHUTCHMED China Announces Diverse Board Leadership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App